Gut-brain communication in COVID-19: molecular mechanisms, mediators, biomarkers, and therapeutics. (2nd September 2022)
- Record Type:
- Journal Article
- Title:
- Gut-brain communication in COVID-19: molecular mechanisms, mediators, biomarkers, and therapeutics. (2nd September 2022)
- Main Title:
- Gut-brain communication in COVID-19: molecular mechanisms, mediators, biomarkers, and therapeutics
- Authors:
- Wais, Tameena
Hasan, Mehde
Rai, Vikrant
Agrawal, Devendra K. - Abstract:
- ABSTRACT: Introduction: Infection with COVID-19 results in acute respiratory symptoms followed by long COVID multi-organ effects presenting with neurological, cardiovascular, musculoskeletal, and gastrointestinal (GI) manifestations. Temporal relationship between gastrointestinal and neurological symptoms is unclear but warranted for exploring better clinical care for COVID-19 patients. Areas covered: We critically reviewed the temporal relationship between gut-brain axis after SARS-CoV-2 infection and the molecular mechanisms involved in neuroinvasion following GI infection. Mediators are identified that could serve as biomarkers and therapeutic targets in SARS-CoV-2. We discussed the potential therapeutic approaches to mitigate the effects of GI infection with SARS-CoV-2. Expert opinion: Altered gut microbiota cause increased expression of various mediators, including zonulin causing disruption of tight junction. This stimulates enteric nervous system and signals to CNS precipitating neurological sequalae. Published reports suggest potential role of cytokines, immune cells, B(0)AT1 (SLC6A19), ACE2, TMRSS2, TMPRSS4, IFN-γ, IL-17A, zonulin, and altered gut microbiome in gut-brain axis and associated neurological sequalae. Targeting these mediators and gut microbiome to improve immunity will be of therapeutic significance. In-depth research and well-designed large-scale population-based clinical trials with multidisciplinary and collaborative approaches are warranted.ABSTRACT: Introduction: Infection with COVID-19 results in acute respiratory symptoms followed by long COVID multi-organ effects presenting with neurological, cardiovascular, musculoskeletal, and gastrointestinal (GI) manifestations. Temporal relationship between gastrointestinal and neurological symptoms is unclear but warranted for exploring better clinical care for COVID-19 patients. Areas covered: We critically reviewed the temporal relationship between gut-brain axis after SARS-CoV-2 infection and the molecular mechanisms involved in neuroinvasion following GI infection. Mediators are identified that could serve as biomarkers and therapeutic targets in SARS-CoV-2. We discussed the potential therapeutic approaches to mitigate the effects of GI infection with SARS-CoV-2. Expert opinion: Altered gut microbiota cause increased expression of various mediators, including zonulin causing disruption of tight junction. This stimulates enteric nervous system and signals to CNS precipitating neurological sequalae. Published reports suggest potential role of cytokines, immune cells, B(0)AT1 (SLC6A19), ACE2, TMRSS2, TMPRSS4, IFN-γ, IL-17A, zonulin, and altered gut microbiome in gut-brain axis and associated neurological sequalae. Targeting these mediators and gut microbiome to improve immunity will be of therapeutic significance. In-depth research and well-designed large-scale population-based clinical trials with multidisciplinary and collaborative approaches are warranted. Investigating the temporal relationship between organs involved in long-term sequalae is critical due to evolving variants of SARS-CoV-2. … (more)
- Is Part Of:
- Expert review of clinical immunology. Volume 18:Number 9(2022)
- Journal:
- Expert review of clinical immunology
- Issue:
- Volume 18:Number 9(2022)
- Issue Display:
- Volume 18, Issue 9 (2022)
- Year:
- 2022
- Volume:
- 18
- Issue:
- 9
- Issue Sort Value:
- 2022-0018-0009-0000
- Page Start:
- 947
- Page End:
- 960
- Publication Date:
- 2022-09-02
- Subjects:
- ACE-2 receptor -- COVID-19 -- enteric nervous system -- gastrointestinal tract -- Gut-brain axis
Clinical immunology -- Periodicals
616.079 - Journal URLs:
- http://www.tandfonline.com/toc/ierm20/current ↗
http://www.future-drugs.com/loi/eci ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/1744666X.2022.2105697 ↗
- Languages:
- English
- ISSNs:
- 1744-666X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3842.002985
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store - Ingest File:
- 23927.xml